More radiation may decrease breast cancer recurrence risk in some patients
the ONA take:
After conservation surgery, some women who undergo additional radiation given to the lymph nodes along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence, according to a study in the New England Journal of Medicine.
Researchers led by Tim Whelan, MD, of McMaster University’s Michael G. DeGroote School of Medicine looked at women with axillary node-positive or high-risk node-negative breast cancer in order to determine whether adding regional node irradiation to whole-breast irradiation proved more beneficial than whole-breast irradiation alone.
More than 1,800 patients were included in the 14-year study as part of NCIC Clinical Trials Group at Queen’s University in Ontario.
They found that additional radiation to the surrounding lymph nodes reduced risk of subsequence recurrence both locally and at sites distant from the breast.
“This study is important because it shows that additional radiation to the surrounding lymph nodes provides added benefit to women, particularly those with involvement of the lymph nodes in the axilla,” Dr. Whelan said. “Further research is necessary to determine which women are most likely to benefit and who may avoid the additional radiation.”
Some women who undergo additional radiation along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|